Abstract
Purine nucleotides are necessary for various biological processes related to cell proliferation. Despite their importance in DNA and RNA synthesis, cellular signaling, and energy-dependent reactions, the impact of changes in cellular purine levels on cell physiology remains poorly understood. Here, we find that purine depletion stimulates cell migration, despite effective reduction in cell proliferation. Blocking purine synthesis triggers a shunt of glycolytic carbon into the serine synthesis pathway, which is required for the induction of cell migration upon purine depletion. The stimulation of cell migration upon a reduction in intracellular purines required one-carbon metabolism downstream of de novo serine synthesis. Decreased purine abundance and the subsequent increase in serine synthesis triggers an epithelial-mesenchymal transition (EMT) and, in cancer models, promotes metastatic colonization. Thus, reducing the available pool of intracellular purines re-routes metabolic flux from glycolysis into de novo serine synthesis, a metabolic change that stimulates a program of cell migration.
Original language | English (US) |
---|---|
Article number | 2698 |
Journal | Nature communications |
Volume | 13 |
Issue number | 1 |
DOIs | |
State | Published - Dec 2022 |
Funding
We thank Prof. Matthew Vander Heiden (Massachusetts Institute of Technology, Cambridge, MA) for the PKM2 wild-type and knockout MEFs and materials, Marc Morgan and Ali Shilatifard for providing us with the guide RNA targeting human P53, Min Yuan for assistance with mass spectrometry, and Vijayashree Ramesh for assistance with tail-vein injections. This research was supported by grants from the NIH: R01GM143236 (G.H.), R35-CA197459 (B.D.M.), P01-CA120964 (B.D.M. and J.A.), R00-CA194192, R01-GM135587, R01GM143334 (I.B.-S.); a Welch foundation award (I-2067-20210327(G.H.)); a TS Alliance Research Grants Program award (885252 (G.H.)), a LAM Foundation Career Development and Established Investigator Awards (LAM0127C01-18, LAM0151E01-22) (I.B.-S.); a TSC Alliance postdoctoral fellowship (SP0057487) (E.V.); and a Rothberg Courage Award from the TSC Alliance (B.D.M.). A.T. was supported by an Emmy Noether Award from the German Research Foundation (DFG, 467788900) and the Ministry of Culture and Science of the State of North Rhine-Westphalia (NRW-Nachwuchsgruppenprogramm). G.H. is recipient of a CPRIT Scholar (CPRIT; RR190087) and a V Scholar (V2021-019) awards. We thank Prof. Matthew Vander Heiden (Massachusetts Institute of Technology, Cambridge, MA) for the PKM2 wild-type and knockout MEFs and materials, Marc Morgan and Ali Shilatifard for providing us with the guide RNA targeting human P53, Min Yuan for assistance with mass spectrometry, and Vijayashree Ramesh for assistance with tail-vein injections. This research was supported by grants from the NIH: R01GM143236 (G.H.), R35-CA197459 (B.D.M.), P01-CA120964 (B.D.M. and J.A.), R00-CA194192, R01-GM135587, R01GM143334 (I.B.-S.); a Welch foundation award (I-2067-20210327(G.H.)); a TS Alliance Research Grants Program award (885252 (G.H.)), a LAM Foundation Career Development and Established Investigator Awards (LAM0127C01-18, LAM0151E01-22) (I.B.-S.); a TSC Alliance postdoctoral fellowship (SP0057487) (E.V.); and a Rothberg Courage Award from the TSC Alliance (B.D.M.). A.T. was supported by an Emmy Noether Award from the German Research Foundation (DFG, 467788900) and the Ministry of Culture and Science of the State of North Rhine-Westphalia (NRW-Nachwuchsgruppenprogramm). G.H. is recipient of a CPRIT Scholar (CPRIT; RR190087) and a V Scholar (V2021-019) awards.
ASJC Scopus subject areas
- General Chemistry
- General Biochemistry, Genetics and Molecular Biology
- General Physics and Astronomy